Physician Practice

As USP looms, access your compliance of medication compounding standards now

Medical Environment Update, September 1, 2018

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Medical Environment Update.

 Examine your hospital’s medication compounding process and your compliance level with upcoming standards as The Joint Commission (TJC) signals its increasing focus on compounding as a problem area.

In January, TJC unveiled a Medication Compounding Certification (MCC) program that’s open to all compounding pharmacies, not just those with TJC accreditation. The accreditor also called upon healthcare providers to work toward the elimination of medication compounding–related infections (MCRI) like the 2012 meningitis outbreak connected to a Boston company. Almost 800 patients were infected and more than 70 died.

“The health care community, including The Joint Commission, recognize that as the need for compounded medications continues to grow it is more important than ever to ensure safe policies and procedures are being appropriately and effectively implemented to prevent patient harm,” wrote Robert Campbell, PharmD, TJC field surveyor, in a TJC blog post in April.

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Medical Environment Update.

Most Popular